[1] |
FU Xiaoyu, KONG Deguang, LI Juanjuan.
Treatment progress of triple positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
|
[2] |
LUO Shiping, ZHANG Jie, YU Yushuai, SONG Chuangui.
Advances in targeted therapy for HER2-positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 876-886.
|
[3] |
WANG Chaoyi, SONG Qiang, XIONG Xin, WANG Mengyuan.
Research progress on diagnosis and treatment of granulomatous lobular mastitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 910-917.
|
[4] |
WANG Juan, LIU Weiying, YE Yucai, FU Wenli, ZHANG Sha, LI Leping.
Research progress of norepinephrine reuptake inhibitor combined with antimuscarinic in the treatment of obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 714-720.
|
[5] |
LI Shuang, HAN Shuzhen, DAI Yuting, XIU Minghui, DU Xianqin, HE Jianzheng, LIN Xingyao.
Progress in the prevention and treatment of traditional Chinese medicine based on the mechanism of intestinal injury of various chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 583-593.
|
[6] |
TAO Yijia, YANG Chun, LIU Cunming .
Progress in clinical application of topical anesthesia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 594-600.
|
[7] |
LI Chenhao, YU Xihua, YAN Wenhao, CHAI Yuxia, LI Yanyan, LI Kun, LI Zeyun.
Research progress on the relationship between pediatric epilepsy and vitamin D
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1299-1306.
|
[8] |
LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling.
Research progress on the antitumor activity of costunolide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176.
|
[9] |
DANG Yangbin, LIANG Yuxin, WANG Tiancheng.
Research progress on the related treatment of progressive myoclonic epilepsy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1184-1194.
|
[10] |
LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, .
Regulatory mechanism of LDLR and research progress of its related diseases and drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954.
|
[11] |
JIA Tao, TENG Jinliang.
New narcotic analgesics: esketamine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 834-840.
|
[12] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[13] |
SHI Jingbin, XIONG Yang.
Research progress on interaction between tumor microenvironment and breast cancer cells leading to tumor metastasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 562-574.
|
[14] |
XU Jianfei, LIN Li.
Research progress in pharmacological and non-pharmacological treatments of hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441.
|
[15] |
LIU Guijian, CHENG Kuan, ZHU Wenqing, GE Junbo.
Progress of hypertension pharmacological treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 446-449.
|